Cantabio Pharmaceuticals, Purdue Research Foundation sign cooperation agreement to investigate targeting of DJ-1 protein for treating Parkinson's disease, other neurodegenerative diseases San Francisco, July 11, 2016 (GLOBE NEWSWIRE) --            SAN FRANCISCO AND WEST LAFAYETTE - Cantabio Pharmaceuticals, Inc. (OTCQB: CTBO) on Monday (July 11) announced the signing of an...